{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:58:20Z","timestamp":1787507900886,"version":"build-2736575974"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"1206","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Special Research Project for the Affiliated Teaching Hospitals of Wannan Medical College","award":["JXYY202111"],"award-info":[{"award-number":["JXYY202111"]}]},{"name":"Anhui Provincial Scientific Research Project for Higher Education Institutions","award":["2024AH050694"],"award-info":[{"award-number":["2024AH050694"]}]},{"name":"Anhui Province Health Research Project","award":["AHWJ2024Aa20554"],"award-info":[{"award-number":["AHWJ2024Aa20554"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>It remains unclear whether pan-immune-inflammation value (PIV) and systemic immune-inflammation index (SII) can predict treatment outcomes in Crohn\u2019s disease (CD) patients receiving infliximab. This study explored the role of PIV and SII in predicting treatment response and prognosis in CD patients receiving biologics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Clinical data of 160 patients with CD were retrospectively collected from Anqing First People\u2019s Hospital in China. Patients were classified into effective and ineffective groups based on therapeutic response. Additionally, 60 healthy controls were enrolled. Serum levels of PIV and SII were measured in all participants. The effectiveness of infliximab was evaluated based on Crohn\u2019s Disease Activity Index. Clinical remission was defined as a Crohn\u2019s Disease Activity Index score &amp;lt;150, while a reduction of \u226570 points from baseline indicated clinical response.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The effective group included 125 patients (mean age, 34.5\u2009\u00b1\u200910.2\u00a0years; 68 men [54.4%]), and the ineffective group included 35 patients (mean age, 36.1\u2009\u00b1\u20099.8\u00a0years; 18 men [51.4%]). The healthy control group covered 60 individuals (mean age, 33.8\u2009\u00b1\u200911.1\u00a0years; 32 men [53.3%]). Patients in the high SII group demonstrated a markedly elevated hazard ratio (HR\u2009=\u200920.786, P\u2009&amp;lt;\u2009.001). A higher PIV was associated with better prognosis (HR\u2009=\u20090.386, 95% confidence interval: 0.228\u20131.655, P\u2009=\u2009.011). Conversely, a higher SII was associated with worse prognosis (HR\u2009=\u200920.786, 95% confidence interval: 9.412\u201345.902, P\u2009&amp;lt;\u2009.001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Both PIV and the SII are useful in predicting efficacy of CD patients treated with biologics. Compared with SII, PIV is a better choice.<\/jats:p>\n                    <jats:p>Key messages What is already known on this topic: Infliximab is the most efficacious and widely used biologic for inducing remission in moderate-to-severe Crohn\u2019s disease. SII and PIV have been validated as prognostic indicators in many diseases. What this study adds: Higher PIV and SII both have positive effects on predicting the prognosis of patients with Crohn\u2019s disease. Compared with the SII, the PIV holds greater significance in predicting the clinical outcomes for patients with Crohn\u2019s disease. How this study might affect research, practice or policy: PIV and SII may aid in risk stratification and individualized treatment planning in Crohn\u2019s disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/postmj\/qgaf172","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T11:50:22Z","timestamp":1758628222000},"page":"378-384","source":"Crossref","is-referenced-by-count":3,"title":["Pan-immune-inflammation value and systemic immune-inflammation index predict the clinical efficacy of biological agents in Crohn\u2019s disease"],"prefix":"10.1093","volume":"102","author":[{"given":"Bin","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Gastrointestinal Surgery, Anqing First People\u2019s Hospital Affiliated to Anhui Medical University , 187 Huazhong Road, Anqing 246000, Anhui Province ,","place":["China"]},{"name":"Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Universiti Malaysia Sabah , Jalan UMS, Kota Kinabalu 88400, Sabah ,","place":["Malaysia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daoli","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Anqing First People\u2019s Hospital Affiliated to Anhui Medical University , 187 Huazhong Road, Anqing 246000, Anhui Province ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongbin","family":"Qi","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Anqing First People\u2019s Hospital Affiliated to Anhui Medical University , 187 Huazhong Road, Anqing 246000, Anhui Province ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7443-9449","authenticated-orcid":false,"given":"Caroline","family":"Sunggip","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Universiti Malaysia Sabah , Jalan UMS, Kota Kinabalu 88400, Sabah ,","place":["Malaysia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"key":"2026031710061071500_ref1","doi-asserted-by":"publisher","first-page":"01131","DOI":"10.1016\/j.cgh.2024.12.006","article-title":"Modified Crohn\u2019s disease exclusion diet maintains remission in pediatric Crohn\u2019s disease: randomized controlled trial","volume":"S1542-3565","author":"Sigall Boneh","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026031710061071500_ref2","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s00423-023-02856-x","article-title":"State-of-the-art surgery for Crohn\u2019s disease: part III\u2014perianal Crohn\u2019s disease","volume":"408","author":"Scheurlen","year":"2023","journal-title":"Langenbecks Arch Surg"},{"key":"2026031710061071500_ref3","doi-asserted-by":"publisher","first-page":"430","DOI":"10.5009\/gnl220005","article-title":"Early infliximab trough levels predict the long-term efficacy of infliximab in a randomized controlled trial in patients with active Crohn\u2019s disease comparing CT-P13 and originator infliximab","volume":"17","author":"Park","year":"2023","journal-title":"Gut Liver"},{"key":"2026031710061071500_ref4","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3109\/00365521.2010.536254","article-title":"Cut-off levels and diagnostic accuracy of infliximab trough levels and anti-infliximab antibodies in Crohn\u2019s disease","volume":"46","author":"Steenholdt","year":"2011","journal-title":"Scand J Gastroenterol"},{"key":"2026031710061071500_ref5","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1093\/jcag\/gwz018","article-title":"Canadian association of gastroenterology clinical practice guideline for the medical management of pediatric luminal Crohn\u2019s disease","volume":"2","author":"Mack","year":"2019","journal-title":"J Can Assoc Gastroenterol"},{"key":"2026031710061071500_ref6","doi-asserted-by":"publisher","first-page":"e0313503","DOI":"10.1371\/journal.pone.0313503","article-title":"Predictive role of the peripheral blood inflammation indices neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and systemic immunoinflammatory index (SII) for age-related cataract risk","volume":"19","author":"Li","year":"2024","journal-title":"PLoS One"},{"key":"2026031710061071500_ref7","doi-asserted-by":"publisher","first-page":"102148","DOI":"10.1016\/j.cimid.2024.102148","article-title":"Clinical importance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and systemic immune-inflammation index in dogs with leishmaniasis","volume":"107","author":"Dur\u00e1n-Galea","year":"2024","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"2026031710061071500_ref8","doi-asserted-by":"publisher","first-page":"651","DOI":"10.3390\/cancers16030651","article-title":"Comparison of PIV and other immune inflammation markers of oncological and survival outcomes in patients undergoing radical cystectomy","volume":"16","author":"Russo","year":"2024","journal-title":"Cancers (Basel)"},{"key":"2026031710061071500_ref9","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.cgh.2011.11.026","article-title":"Induction and maintenance therapy with infliximab for children with moderate to severe ulcerative colitis","volume":"10","author":"Hyams","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026031710061071500_ref10","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1053\/j.gastro.2016.11.041","article-title":"American Gastroenterological Institute guideline on the management of Crohn\u2019s disease after surgical resection: clinical decision support tool","volume":"152","author":"American Gastroenterological Association","year":"2017","journal-title":"Gastroenterology"},{"key":"2026031710061071500_ref11","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/ecco-jcc\/jjz180","article-title":"ECCO guidelines on therapeutics in Crohn\u2019s disease: medical treatment","volume":"14","author":"Torres","year":"2020","journal-title":"J Crohns Colitis"},{"key":"2026031710061071500_ref12","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1053\/j.gastro.2019.04.021","article-title":"Crohn\u2019s disease exclusion diet plus partial enteral nutrition induces sustained remission in a randomized controlled trial","volume":"157","author":"Levine","year":"2019","journal-title":"Gastroenterology"},{"key":"2026031710061071500_ref13","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S2468-1253(24)00034-7","article-title":"A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trial","volume":"9","author":"Noor","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2026031710061071500_ref14","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s40795-025-01127-w","article-title":"Evaluation of Streptococcus faecalis, Clostridium butyricum, Bacillus mesentericus, Lactobacillus sporogenes, Saccharomyces boulardi multistrain probiotic formulation in acute gastroenteritis: a real-world observational study (MAESTRO)","volume":"11","author":"Patel","year":"2025","journal-title":"BMC Nutr"},{"key":"2026031710061071500_ref15","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1007\/s00330-008-1290-5","article-title":"Comparison of sonographically measured bowel wall vascularity, histology, and disease activity in Crohn\u2019s disease","volume":"19","author":"Drews","year":"2009","journal-title":"Eur Radiol"},{"key":"2026031710061071500_ref16","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1097\/MEG.0000000000002969","article-title":"A comparison between the bowel ultrasound score and international bowel ultrasound segmental activity score based on ileocolonoscopy in patients with Crohn\u2019s disease","volume":"37","author":"Yuksel","year":"2025","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2026031710061071500_ref17","doi-asserted-by":"publisher","first-page":"452","DOI":"10.3390\/genes14020452","article-title":"MIF variant rs755622 is associated with severe Crohn\u2019s disease and better response to anti-TNF adalimumab therapy","volume":"14","author":"Jezernik","year":"2023","journal-title":"Genes (Basel)"},{"key":"2026031710061071500_ref18","doi-asserted-by":"publisher","first-page":"1534018","DOI":"10.3389\/fendo.2025.1534018","article-title":"Pan-immune-inflammation value and its association with all-cause and cause-specific mortality in the general population: a nationwide cohort study","volume":"16","author":"Zhang","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2026031710061071500_ref19","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S0016-5085(76)80163-1","article-title":"Development of a Crohn\u2019s disease activity index. National Cooperative Crohn\u2019s Disease Study","volume":"70","author":"Best","year":"1976","journal-title":"Gastroenterology"},{"key":"2026031710061071500_ref20","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ejca.2021.03.043","article-title":"The pan-immune-inflammation value in microsatellite instability-high metastatic colorectal cancer patients treated with immune checkpoint inhibitors","volume":"150","author":"Corti","year":"2021","journal-title":"Eur J Cancer"},{"key":"2026031710061071500_ref21","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/ajg.2009.545","article-title":"Fecal calprotectin correlates more closely with the simple endoscopic score for Crohn\u2019s disease (SES-CD) than CRP, blood leukocytes, and the CDAI","volume":"105","author":"Schoepfer","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"2026031710061071500_ref22","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1097\/WON.0b013e3181f91082","article-title":"Age differences in patients evaluated for constipation: constipation characteristics, symptoms, and bowel and dietary habits","volume":"37","author":"McCrea","year":"2010","journal-title":"J Wound Ostomy Continence Nurs"},{"key":"2026031710061071500_ref23","doi-asserted-by":"publisher","first-page":"19040","DOI":"10.1038\/s41598-020-76115-0","article-title":"Prognostic significance of the controlling nutritional status (CONUT) score in predicting postoperative complications in patients with Crohn\u2019s disease","volume":"10","author":"Dong","year":"2020","journal-title":"Sci Rep"},{"key":"2026031710061071500_ref24","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1111\/jgh.15540","article-title":"Predictability of simple endoscopic score for Crohn\u2019s disease for postoperative outcomes in Crohn\u2019s disease","volume":"36","author":"Akiyama","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"key":"2026031710061071500_ref25","doi-asserted-by":"publisher","first-page":"111257","DOI":"10.1016\/j.humimm.2025.111257","article-title":"Exhaustion profile on classical monocytes after LPS stimulation on Crohn\u2019s disease patients","volume":"86","author":"Oliveira","year":"2025","journal-title":"Hum Immunol"},{"key":"2026031710061071500_ref26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/189341","article-title":"Procoagulatory state in inflammatory bowel diseases is promoted by impaired intestinal barrier function","volume":"2015","author":"Pastorelli","year":"2015","journal-title":"Gastroenterol Res Pract"},{"key":"2026031710061071500_ref27","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1245\/s10434-023-14430-2","article-title":"Pretreatment pan-immune-inflammation value (PIV) in predicting therapeutic response and clinical outcomes of neoadjuvant immunochemotherapy for esophageal squamous cell carcinoma","volume":"31","author":"Feng","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"2026031710061071500_ref28","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.pharmthera.2016.09.011","article-title":"Chemokines, cytokines and exosomes help tumors to shape inflammatory microenvironment","volume":"168","author":"Atretkhany","year":"2016","journal-title":"Pharmacol Ther"},{"key":"2026031710061071500_ref29","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s10020-022-00562-w","article-title":"Inhibition of platelet activation suppresses reactive enteric glia and mitigates intestinal barrier dysfunction during sepsis","volume":"28","author":"Cheng","year":"2022","journal-title":"Mol Med"},{"key":"2026031710061071500_ref30","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s10020-022-00556-8","article-title":"Inhibition of platelet activation suppresses reactive enteric glia and mitigates intestinal barrier dysfunction during sepsis","volume":"28","author":"Cheng","year":"2022","journal-title":"Mol Med"},{"key":"2026031710061071500_ref31","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.2169\/internalmedicine.53.2627","article-title":"Slight increases in the disease activity index and platelet count imply the presence of active intestinal lesions in C-reactive protein-negative Crohn\u2019s disease patients","volume":"53","author":"Nakarai","year":"2014","journal-title":"Intern Med"}],"container-title":["Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/102\/1206\/378\/64711937\/qgaf172.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/102\/1206\/378\/64711937\/qgaf172.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T14:06:16Z","timestamp":1773756376000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pmj\/article\/102\/1206\/378\/8286971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":31,"journal-issue":{"issue":"1206","published-online":{"date-parts":[[2025,10,15]]},"published-print":{"date-parts":[[2026,3,17]]}},"URL":"https:\/\/doi.org\/10.1093\/postmj\/qgaf172","relation":{},"ISSN":["0032-5473","1469-0756"],"issn-type":[{"value":"0032-5473","type":"print"},{"value":"1469-0756","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2025,10,15]]}}}